Redeye is positive about SenzaGen’s acquisition of ToxHub, an Italian toxicology services company sp...
Redeye leaves a short comment on Calmark on the back of changes in management.
Ferroamp redovisar hög tillväxt mot Q3 förra året men försäljningen minskar sekventiellt.
In its Q322 report, Mendus highlighted key developments in the period, and some significant post-per...
Sales and EBITDA below ABGSCe in Q3 Digital Identity up-and-coming, Algo hit by macro Share trades a...
Företagsparken grows despite macro headwinds Q3 NAV decline largely explains estimate cuts Share tra...
Investors House reported Q3 revenues of EUR 1.9m, 1% above our estimate.
Med Q3-rapporten presenterad står det klart att Koncernen överträffade vårt försäljningsestimat, var...
Redeye retains its positive view of Infracom following its Q3 report.
Redeye is sad to hear that CEO Anders Kottenauer is leaving the company.
Redeye is encouraged to see the announcement of a Coating Service order for electrolysis plates.
We expect a decent Q3 report on 18 November. We forecast group sales will grow 28% (2 pp organic), u...
Redeye retains its positive view on Speqta following a solid Q3 report.
Redeye retains its positive view of CombinedX following a soft Q3 report, hurt by high employee turn...
Redeye provides a short comment on SenzaGen’s acquisition of ToxHub, an Italian toxicology services ...
Learning to Sleep publicerade den 11 november 2022 bolagets delårsrapport för det tredje kvartalet 2...
Angler Gaming ökar kraftigt omsättning och rörelseresultat sekventiellt vilket vittnar om ett trendb...
Redeye comments on Mendus’ Q3 2022 report, as the company is approaching a crucial survival readout ...
Large net profit beat from loan loss reversals… … and exploitation of deferred tax asset PBLL miss l...
Redeye comments on Isofol’s Q3 2022 report, and we expect the company to communicate a clearer path ...
